All comparisons

Educational Wellness Information Only

This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.

Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.

Fat loss comparison

5-Amino-1MQ vs Semaglutide

An educational, source-based comparison of 5-Amino-1MQ and Semaglutide — how each peptide works, what it's researched for, and what to know before going deeper.

Metabolic · Small Molecule
5-Amino-1MQ

Small-molecule NNMT inhibitor researched for fat metabolism.

Mechanism

Not a peptide but commonly grouped in peptide research. A selective inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme overexpressed in obese adipose tissue. Inhibition increases SAM and NAD+ availability, increasing adipocyte energy expenditure in animal models.

Research areas
  • Diet-induced obesity (rodent)
  • White adipose tissue energy expenditure
  • Age-related muscle function
Considerations
  • Investigational; no human clinical trials yet.
  • Not FDA-approved.
Full 5-Amino-1MQ profile →
Metabolic · Incretin
Semaglutide

FDA-approved GLP-1 agonist for diabetes and obesity.

Mechanism

A long-acting GLP-1 receptor agonist that enhances glucose-dependent insulin secretion, suppresses glucagon, slows gastric emptying, and reduces appetite via central GLP-1 receptors.

Research areas
  • Type 2 diabetes (Ozempic, Rybelsus)
  • Obesity / chronic weight management (Wegovy)
  • Cardiovascular risk reduction (SELECT trial)
Considerations
  • FDA-approved with established safety profile but real side effects (GI, pancreatitis risk, gallbladder events).
  • Requires physician oversight and prescription.
  • Compounded versions vary in quality.
Full Semaglutide profile →

5-Amino-1MQ vs Semaglutide — Key differences

  • Class: 5-Amino-1MQ is classified as Metabolic · Small Molecule, while Semaglutide is Metabolic · Incretin.
  • Primary research focus: 5-Amino-1MQdiet-induced obesity (rodent); Semaglutidetype 2 diabetes (ozempic, rybelsus).
  • Tag: Metabolic vs Weight loss.

Related comparisons